TY  - GEN
AU  - Sibon,David
AU  - Ertault,Marjane
AU  - Al Nawakil,Chadi
AU  - de Bazelaire,Cédric
AU  - Franchi,Patricia
AU  - Brière,Josette
AU  - de Kerviler,Eric
AU  - Beranger,Nathalie
AU  - Thieblemont,Catherine
AU  - Brice,Pauline
TI  - Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients
SN  - 1365-2141
PY  - 2012///0608
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bleomycin
KW  - Dacarbazine
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Epirubicin
KW  - Etoposide
KW  - Female
KW  - Follow-Up Studies
KW  - Hodgkin Disease
KW  - mortality
KW  - Humans
KW  - Ifosfamide
KW  - Male
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Prospective Studies
KW  - Recurrence
KW  - Stem Cell Transplantation
KW  - Survival Rate
KW  - Transplantation, Autologous
KW  - Vinblastine
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1111/j.1365-2141.2011.08594.x
ER  -